Literature DB >> 17693623

Regulation of neutral sphingomyelinase-2 by GSH: a new insight to the role of oxidative stress in aging-associated inflammation.

Kristina Rutkute1, Reto H Asmis, Mariana N Nikolova-Karakashian.   

Abstract

Oxidative stress and inflammation are fundamental for the onset of aging and appear to be causatively linked. Previously, we reported that hepatocytes from aged rats, compared with young rats, are hyperresponsive to interleukin-1beta (IL-1beta) stimulation and exhibit more potent c-Jun N-terminal kinase (JNK) activation and attenuated interleukin-1 receptor-associated kinase-1 (IRAK-1) degradation. An age-related increase in the activity of neutral sphingomyelinase-2 (NSMase-2), a plasma membrane enzyme, was found to be responsible for the IL-1beta hyperresponsiveness. The results reported here show that increased NSMase activity during aging is caused by a 60-70% decrease in hepatocyte GSH levels. GSH, at concentrations typically found in hepatocytes from young animals, inhibits NSMase activity in a biphasic dose-dependent manner. Inhibition of GSH synthesis in young hepatocytes activates NSMase, causing increased JNK activation and IRAK-1 stabilization in response to IL-1beta, mimicking the hyperresponsiveness typical for aged hepatocytes. Vice versa, increased GSH content in hepatocytes from aged animals by treatment with N-acetylcysteine inhibits NSMase activity and restores normal IL-1beta response. Importantly, the GSH decline, NSMase activation, and IL-1beta hyperresponsiveness are not observed in aged, calorie-restricted rats. In summary, this report demonstrates that depletion of cellular GSH during aging plays an important role in regulating the hepatic response to IL-1beta by inducing NSMase-2 activity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17693623      PMCID: PMC3010975          DOI: 10.1194/jlr.M700227-JLR200

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  51 in total

1.  Lag1p and Lac1p are essential for the Acyl-CoA-dependent ceramide synthase reaction in Saccharomyces cerevisae.

Authors:  S Schorling; B Vallée; W P Barz; H Riezman; D Oesterhelt
Journal:  Mol Biol Cell       Date:  2001-11       Impact factor: 4.138

2.  Effects of aging on the susceptibility to the toxic effects of cyclosporin A in rats. Changes in liver glutathione and antioxidant enzymes.

Authors:  J Palomero; A I Galán; M E Muñoz; M J Tuñón; J González-Gallego; R Jiménez
Journal:  Free Radic Biol Med       Date:  2001-04-15       Impact factor: 7.376

Review 3.  The inflammation hypothesis of aging: molecular modulation by calorie restriction.

Authors:  H Y Chung; H J Kim; J W Kim; B P Yu
Journal:  Ann N Y Acad Sci       Date:  2001-04       Impact factor: 5.691

4.  (R)-alpha-lipoic acid reverses the age-associated increase in susceptibility of hepatocytes to tert-butylhydroperoxide both in vitro and in vivo.

Authors:  T M Hagen; V Vinarsky; C M Wehr; B N Ames
Journal:  Antioxid Redox Signal       Date:  2000       Impact factor: 8.401

5.  Purification and characterization of a magnesium-dependent neutral sphingomyelinase from bovine brain.

Authors:  K Bernardo; O Krut; K Wiegmann; D Kreder; M Micheli; R Schäfer; A Sickman; W E Schmidt; J M Schröder; H E Meyer; K Sandhoff; M Krönke
Journal:  J Biol Chem       Date:  2000-03-17       Impact factor: 5.157

6.  Glutathione peroxidase-1 overexpression prevents ceramide production and partially inhibits apoptosis in doxorubicin-treated human breast carcinoma cells.

Authors:  V Gouazé; M E Mirault; S Carpentier; R Salvayre; T Levade; N Andrieu-Abadie
Journal:  Mol Pharmacol       Date:  2001-09       Impact factor: 4.436

7.  Characterization of interleukin-1 receptor-associated kinase in normal and endotoxin-tolerant cells.

Authors:  L Li; S Cousart; J Hu; C E McCall
Journal:  J Biol Chem       Date:  2000-07-28       Impact factor: 5.157

8.  Enhanced anti-oxidant protection of liver membranes in long-lived rats fed on a coenzyme Q10-supplemented diet.

Authors:  Rosario I Bello; Consuelo Gómez-Díaz; María I Burón; Francisco J Alcaín; Plácido Navas; José M Villalba
Journal:  Exp Gerontol       Date:  2005 Aug-Sep       Impact factor: 4.032

9.  Activation of sphingolipid turnover and chronic generation of ceramide and sphingosine in liver during aging.

Authors:  S A Lightle; J I Oakley; M N Nikolova-Karakashian
Journal:  Mech Ageing Dev       Date:  2000-12-01       Impact factor: 5.432

10.  Effects of reduced and oxidized glutathione on sphingomyelinase activity and contents of sphingomyelin and lipid peroxidation products in murine liver.

Authors:  A N Tsyupko; L B Dudnik; R P Evstigneeva; A V Alessenko
Journal:  Biochemistry (Mosc)       Date:  2001-09       Impact factor: 2.487

View more
  39 in total

1.  Neutral sphingomyelinase 2 activity and protein stability are modulated by phosphorylation of five conserved serines.

Authors:  Simone Filosto; Majid Ashfaq; Samuel Chung; William Fry; Tzipora Goldkorn
Journal:  J Biol Chem       Date:  2011-11-10       Impact factor: 5.157

2.  Neutral sphingomyelinase activation precedes NADPH oxidase-dependent damage in neurons exposed to the proinflammatory cytokine tumor necrosis factor-α.

Authors:  Brian M Barth; Sally J Gustafson; Thomas B Kuhn
Journal:  J Neurosci Res       Date:  2011-09-19       Impact factor: 4.164

3.  Exosome reduction in vivo is associated with lower amyloid plaque load in the 5XFAD mouse model of Alzheimer's disease.

Authors:  Michael B Dinkins; Somsankar Dasgupta; Guanghu Wang; Gu Zhu; Erhard Bieberich
Journal:  Neurobiol Aging       Date:  2014-02-15       Impact factor: 4.673

4.  Glycosylated sphingolipids and progression to kidney dysfunction in type 1 diabetes.

Authors:  Maria F Lopes-Virella; Nathaniel L Baker; Kelly J Hunt; Samar M Hammad; John Arthur; Gabriel Virella; Richard L Klein
Journal:  J Clin Lipidol       Date:  2019-04-03       Impact factor: 4.766

5.  Neutral sphingomyelinase 2: a novel target in cigarette smoke-induced apoptosis and lung injury.

Authors:  Simone Filosto; Sianna Castillo; Aaron Danielson; Lisa Franzi; Elaine Khan; Nick Kenyon; Jerold Last; Kent Pinkerton; Rubin Tuder; Tzipora Goldkorn
Journal:  Am J Respir Cell Mol Biol       Date:  2010-05-06       Impact factor: 6.914

Review 6.  Lung injury and cancer: Mechanistic insights into ceramide and EGFR signaling under cigarette smoke.

Authors:  Tzipora Goldkorn; Simone Filosto
Journal:  Am J Respir Cell Mol Biol       Date:  2010-06-04       Impact factor: 6.914

7.  Protein phosphatase 2A and neutral sphingomyelinase 2 regulate IRAK-1 protein ubiquitination and degradation in response to interleukin-1beta.

Authors:  Aneta Dobierzewska; Natalia V Giltiay; Sathish Sabapathi; Alexander A Karakashian; Mariana N Nikolova-Karakashian
Journal:  J Biol Chem       Date:  2011-06-27       Impact factor: 5.157

8.  Effect of procysteine on aging-associated changes in hepatic GSH and SMase: evidence for transcriptional regulation of smpd3.

Authors:  Gergana Deevska; Manjula Sunkara; Claudia Karakashian; Benjamin Peppers; Andrew J Morris; Mariana N Nikolova-Karakashian
Journal:  J Lipid Res       Date:  2014-07-21       Impact factor: 5.922

9.  Off-target function of the Sonic hedgehog inhibitor cyclopamine in mediating apoptosis via nitric oxide-dependent neutral sphingomyelinase 2/ceramide induction.

Authors:  Marisa Meyers-Needham; Jocelyn A Lewis; Salih Gencer; R David Sentelle; Sahar A Saddoughi; Christopher J Clarke; Yusuf A Hannun; Haakan Norell; Telma Martins da Palma; Michael Nishimura; Jacqueline M Kraveka; Zohreh Khavandgar; Monzur Murshed; M Ozgur Cevik; Besim Ogretmen
Journal:  Mol Cancer Ther       Date:  2012-03-27       Impact factor: 6.261

10.  Exacerbated innate host response to SARS-CoV in aged non-human primates.

Authors:  Saskia L Smits; Anna de Lang; Judith M A van den Brand; Lonneke M Leijten; Wilfred F van IJcken; Marinus J C Eijkemans; Geert van Amerongen; Thijs Kuiken; Arno C Andeweg; Albert D M E Osterhaus; Bart L Haagmans
Journal:  PLoS Pathog       Date:  2010-02-05       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.